Best of Neurodegenerative Diseases

This Best of Neurodegenerative Diseases brings you a selection of the latest and leading research published in our portfolio. We are highlighting the latest development in diagnosis, treatment, prevention and care of neurodegenerative diseases. This collection collates articles from multiple journals and topics as COVID-19, neuroinflammation, ageing, cognitive decline, molecular pathways of neurodegenerations and public health.

•  
  SUMOylation in Neurodegenerative Diseases
  Princz A. · Tavernarakis N.
  Gerontology 2020;66:122–130 (DOI:10.1159/000502142)

   

•  
  The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
  Pyne J.D. · Brickman A.M.
  Neurodegener Dis 2021;21:1–23 (DOI:10.1159/000518581)

   

•  
  Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson’s Disease and Atypical Parkinsonian Syndromes
  Kaiserova M. · Chudackova M. · Prikrylova Vranova H. · Mensikova K. · Kastelikova A. · Stejskal D. · Kanovsky P.
  Neurodegener Dis 2021;21:30–35 (DOI:10.1159/000520302)

   

•  
  Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease
  He S. · Zhong S. · Liu G. · Yang J.
  Neurodegener Dis 2020;20:55–64 (DOI:10.1159/000511083)

   

•  
  Blunt Traumatic Brain Injury and Alzheimer Pathology
  Jellinger K.A.
  Dement Geriatr Cogn Disord 2022;51:428–433 (DOI:10.1159/000527686)

   

•  
  Pathobiological Subtypes of Alzheimer Disease
  Jellinger K.A.
  Dement Geriatr Cogn Disord 2020;49:321–333 (DOI:10.1159/000508625)

   

•  
  Physical Exercise Ameliorates the Cognitive Function and Attenuates the Neuroinflammation of Alzheimer’s Disease via miR-129–5p
  Li Z. · Chen Q. · Liu J. · Du Y.
  Dement Geriatr Cogn Disord 2020;49:163–169 (DOI:10.1159/000507285)

   

•  
  A 3-Gene-Based Diagnostic Signature in Alzheimer’s Disease
  Wang H. · Zhang Y. · Zheng C. · Yang S. · Chen X. · Wang H. · Gao S.
  Eur Neurol 2022;85:6–13 (DOI:10.1159/000518727)

   

•  
  Neurofilament Light Chain Levels Are Associated with Disease Activity Determined by No Evident Disease Activity in Multiple Sclerosis Patients
  Szilasiová J. · Rosenberger J. · Fedičová M. · Mikula P. · Urban P. · Gdovinová Z. · Vitková M. · Hanes J. · Stevens E.
  Eur Neurol 2021;84:272–279 (DOI:10.1159/000515806)

   

•  
  The Potential of Neurofilament Light as a Biomarker in Alzheimer’s Disease
  Xiong Y.-I. · Meng T. · Luo J. · Zhang H.
  Eur Neurol 2021;84:6–15 (DOI:10.1159/000513008)

   

•  
  From Dementia to Eumentia: A New Approach to Dementia Prevention
  Hachinski V. · Avan A.
  Neuroepidemiology 2022;56:151–156 (DOI:10.1159/000525219)

   

•  
  Descriptive Epidemiology of Neurodegenerative Diseases: What Are the Critical Questions?
  Logroscino G. · Urso D. · Savica R.
  Neuroepidemiology 2022;56:309–318 (DOI:10.1159/000525639)

   

•  
  Traumatic Brain Injury and Risk of Dementia and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
  Gu D. · Ou S. · Liu G.
  Neuroepidemiology 2022;56:4–16 (DOI:10.1159/000520966)

   

•  
  The Central Inflammatory Network: A Hypothalamic fMRI Study of Experimental Endotoxemia in Humans
  Färber N. · Manuel J. · May M. · Foadi N. · Beissner F.
  Neuroimmunomodulation 2022;29:231–247 (DOI:10.1159/000519061)

   

•  
  Integrated Proteomic and Phosphoproteomic Analysis of the Hippocampus in a Mouse Model of Early Life Inflammation
  Wu X. · Gao Y. · Zhu T. · Gu H. · Tong J. · Sun J. · Yang J. · Ji M.
  Neuroimmunomodulation 2023;30:28–41 (DOI:10.1159/000527975)

   

•  
  The Infected Lungs and Brain Interface in COVID-19: The Impact on Cognitive Function
  Joaquim L. · Della Giustina A. · Machado R.S. · Metzker K.L.L. · Bonfante S. · Danielski L.G. · Goldim M.P.S. · Petronilho F.
  Neuroimmunomodulation 2022;29:269–281 (DOI:10.1159/000526653)

   

Connect with Us

Contact Us

If you have any questions, just get in touch with the Editorial Office